ACUITY PCI: A Prospective Trial of Patients With Acute
Coronary Syndromes Undergoing PCI After Randomization to Heparin Plus Glycoprotein
IIb/IIIa Inhibitors vs Bivalirudin With or Without Glycoprotein IIb/IIIa
Inhibitors: 30-Day Clinical and Angiographic Core Laboratory Results